Literature DB >> 10369764

Erythromycin resistance mutations in ribosomal proteins L22 and L4 perturb the higher order structure of 23 S ribosomal RNA.

S T Gregory1, A E Dahlberg.   

Abstract

We have used chemical modification to examine the conformation of 23 S rRNA in Escherichia coli ribosomes bearing erythromycin resistance mutations in ribosomal proteins L22 and L4. Changes in reactivity to chemical probes were observed at several nucleotide positions scattered throughout 23 S rRNA. The L4 mutation affects the reactivity of G799 and U1255 in domain II and that of A2572 in domain V. The L22 mutation influences modification in domain II at positions m5U747, G748, and A1268, as well as at A1614 in domain III and G2351 in domain V. The reactivity of A789 is weakly enhanced by both the L22 and L4 mutations. None of these nucleotide positions has previously been associated with macrolide antibiotic resistance. Interestingly, neither of the ribosomal protein mutations produces any detectable effects at or within the vicinity of A2058 in domain V, the site most frequently shown to confer macrolide resistance when altered by methylation or mutation. Thus, while L22 and L4 bind primarily to domain I of 23 S rRNA, erythromycin resistance mutations in these ribosomal proteins perturb the conformation of residues in domains II, III and V and affect the action of antibiotics known to interact with nucleotide residues in the peptidyl transferase center of domain V. These results support the hypothesis that ribosomal proteins interact with rRNA at multiple sites to establish its functionally active three-dimensional structure, and suggest that these antibiotic resistance mutations act by perturbing the conformation of rRNA. Copyright 1999 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10369764     DOI: 10.1006/jmbi.1999.2839

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  56 in total

1.  Mutation in 23S rRNA responsible for resistance to 16-membered macrolides and streptogramins in Streptococcus pneumoniae.

Authors:  F Depardieu; P Courvalin
Journal:  Antimicrob Agents Chemother       Date:  2001-01       Impact factor: 5.191

Review 2.  Macrolide resistance conferred by base substitutions in 23S rRNA.

Authors:  B Vester; S Douthwaite
Journal:  Antimicrob Agents Chemother       Date:  2001-01       Impact factor: 5.191

3.  Crystal structure of ribosomal protein L4 shows RNA-binding sites for ribosome incorporation and feedback control of the S10 operon.

Authors:  M Worbs; R Huber; M C Wahl
Journal:  EMBO J       Date:  2000-03-01       Impact factor: 11.598

4.  A short fragment of 23S rRNA containing the binding sites for two ribosomal proteins, L24 and L4, is a key element for rRNA folding during early assembly.

Authors:  U Stelzl; K H Nierhaus
Journal:  RNA       Date:  2001-04       Impact factor: 4.942

Review 5.  Resistance to linezolid caused by modifications at its binding site on the ribosome.

Authors:  Katherine S Long; Birte Vester
Journal:  Antimicrob Agents Chemother       Date:  2011-12-05       Impact factor: 5.191

6.  Resistance to quinupristin-dalfopristin due to mutation of L22 ribosomal protein in Staphylococcus aureus.

Authors:  Brigitte Malbruny; Annie Canu; Bülent Bozdogan; Bruno Fantin; Virginie Zarrouk; Sylvie Dutka-Malen; Celine Feger; Roland Leclercq
Journal:  Antimicrob Agents Chemother       Date:  2002-07       Impact factor: 5.191

7.  The extended loops of ribosomal proteins L4 and L22 are not required for ribosome assembly or L4-mediated autogenous control.

Authors:  Janice M Zengel; Adam Jerauld; Andre Walker; Markus C Wahl; Lasse Lindahl
Journal:  RNA       Date:  2003-10       Impact factor: 4.942

8.  Mutations at the accommodation gate of the ribosome impair RF2-dependent translation termination.

Authors:  Dmitry E Burakovsky; Petr V Sergiev; Maria A Steblyanko; Andriy V Kubarenko; Andrey L Konevega; Alexey A Bogdanov; Marina V Rodnina; Olga A Dontsova
Journal:  RNA       Date:  2010-07-28       Impact factor: 4.942

9.  In vitro subminimum inhibitory concentrations of macrolide antibiotics induce macrolide resistance in Mycoplasma pneumoniae.

Authors:  G Ou; Y Liu; Y Tang; X You; Y Zeng; J Xiao; L Chen; M Yu; M Wang; C Zhu
Journal:  Hippokratia       Date:  2015 Jan-Mar       Impact factor: 0.471

10.  Chemistry and biology of macrolide antiparasitic agents.

Authors:  Younjoo Lee; Jun Yong Choi; Hong Fu; Colin Harvey; Sandeep Ravindran; William R Roush; John C Boothroyd; Chaitan Khosla
Journal:  J Med Chem       Date:  2011-03-23       Impact factor: 7.446

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.